The first evidence for the role of NLRP3 in IL-1β secretion in AD was provided by Halle et al., who showed that NLRP3 dependent caspase-1 activation occurred in microglia cells after stimulation with Aβ [149]. Here, NLRP3 is linked to Alzheimer disease.